Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells.

scientific article published on 15 October 2013

Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells. is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1031267755
P356DOI10.1186/SCRT336
P8608Fatcat IDrelease_rpquch7ltnahnbalwmrpql2jai
P932PMC publication ID3854702
P698PubMed publication ID24406104
P5875ResearchGate publication ID259650589

P50authorPaula LaranjeiraQ58924808
Cláudia Lobato da SilvaQ82271615
Ana HenriquesQ45911497
Artur PaivaQ47805899
Isabel VeladaQ49804796
Joaquim M CabralQ57837606
Mário GrãosQ58392050
P2093author name stringAndreia Ribeiro
António Martinho
Pedro Andrade
Carla M P Cardoso
Francisco Santos
Hélder Trindade
Cristiana Leite
Sandrine Mendes
Mluísa Pais
P2860cites workMesenchymal stem cells avoid allogeneic rejectionQ21245658
Regulation of interleukin-12 expression in human monocytes: selective priming by interferon-gamma of lipopolysaccharide-inducible p35 and p40 genesQ24317746
Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetesQ24644691
The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cellsQ24678409
Multilineage potential of adult human mesenchymal stem cellsQ27860737
Human mesenchymal stem cells modulate allogeneic immune cell responsesQ28288692
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuliQ29618769
Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the cryptQ29618968
Human mesenchymal stem cells modulate B-cell functionsQ29620705
Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing.Q30157916
Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway.Q31101562
Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentiallyQ33528988
IL-6-dependent PGE2 secretion by mesenchymal stem cells inhibits local inflammation in experimental arthritisQ33769303
Long-lasting inhibitory effects of fetal liver mesenchymal stem cells on T-lymphocyte proliferationQ33916474
Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells.Q34007524
B7-H4 Treatment of T Cells Inhibits ERK, JNK, p38, and AKT ActivationQ34124940
B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytesQ34128389
Mesenchymal stromal cells: current understanding and clinical statusQ34234464
Aggregatibacter actinomycetemcomitans GroEL protein promotes conversion of human CD4+ T cells into IFNγ IL10 producing Tbet+ Th1 cellsQ34477877
The different immunoregulatory functions on dendritic cells between mesenchymal stem cells derived from bone marrow of patients with low-risk or high-risk myelodysplastic syndromesQ34613086
Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cellsQ35166506
Utility of flow cytometric detection of CD69 expression as a rapid method for determining poly- and oligoclonal lymphocyte activation.Q35226762
Mesenchymal stem cells impair in vivo T-cell priming by dendritic cellsQ35409468
Mesenchymal stem cell effects on T-cell effector pathways.Q35558505
Adipose-derived adult stem cells: isolation, characterization, and differentiation potential.Q35567830
CD69 is independently prognostic in chronic lymphocytic leukemia: a comprehensive clinical and biological profiling study.Q35717883
Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiationQ35769073
Human adipose-derived stem cells impair natural killer cell function and exhibit low susceptibility to natural killer-mediated lysisQ35964770
Immunomodulatory effect of mesenchymal stem cells on B cellsQ36105639
TGF-β signaling via Smad4 drives IL-10 production in effector Th1 cells and reduces T-cell trafficking in EAEQ36340416
Adult stem cells in the treatment of autoimmune diseasesQ36508132
Human mesenchymal stem cells inhibit antibody production induced in vitro by allostimulationQ60313622
CD69, CD25, and HLA-DR activation antigen expression on CD3+ lymphocytes and relationship to serum TNF-α, IFN-γ, and sIL-2R levels in agingQ61054681
Toll-Like Receptors 3 and 4 Are Expressed by Human Bone Marrow-Derived Mesenchymal Stem Cells and Can Inhibit Their T-Cell Modulatory Activity by Impairing Notch SignalingQ61638150
Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric OxideQ61645540
Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosusQ61657757
Accessory cell-derived helper signals in human T-cell activation with phytohemagglutinin: induction of interleukin 2-responsiveness by interleukin 6, and production of interleukin 2 by interleukin 1 [corrected]Q67264509
Similar co-stimulation requirements of CD4+ and CD8+ primary T helper cells: role of IL-1 and IL-6 in inducing IL-2 secretion and subsequent proliferationQ68054966
Comparative effects of tumor necrosis factor-alpha and IL-1 beta on mitogen-induced T cell activationQ70051189
Inhibition of human B cell responsiveness by prostaglandin E2Q70161872
Regulation of human B cell proliferation by prostaglandin E2Q70225368
Suppressed PHA activation of T lymphocytes in simulated microgravity is restored by direct activation of protein kinase CQ74530628
Functional aspects of cord blood lymphocytes response to polyclonal and allogeneic activationQ77142499
Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cellsQ79208808
Differentiation potential of mesenchymal stem cells of different originQ80161547
Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-GQ80714885
Semaphorin-3A is expressed by tumor cells and alters T-cell signal transduction and functionQ82097189
Mesenchymal stem cellsQ83591416
Subpopulation composition and activation of T lymphocytes during coculturing with mesenchymal stromal cells in medium with different O(2) contentQ83751058
Characterization and functionality of the CD200-CD200R system during mesenchymal stromal cell interactions with T-lymphocytesQ84105212
Modulated expression of adhesion molecules and galectin-1: role during mesenchymal stromal cell immunoregulatory functionsQ84460527
Adipose-tissue-derived and Wharton's jelly-derived mesenchymal stromal cells suppress lymphocyte responses by secreting leukemia inhibitory factorQ84514926
Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cellsQ84579882
The negative co-signaling molecule b7-h4 is expressed by human bone marrow-derived mesenchymal stem cells and mediates its T-cell modulatory activityQ84595031
[Effect of mesenchymal stem cells on expression of CD69 in cord blood CIK/NK cells and quantity ratio of T regulatory cells in CIK/NK cell culture]Q84747907
Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiationQ84968409
Opposing effect of mesenchymal stem cells on Th1 and Th17 cell polarization according to the state of CD4+ T cell activationQ85121641
Mesenchymal stem cells in immunoregulationQ36547852
Mesenchymal stem cells derived from human induced pluripotent stem cells modulate T-cell phenotypes in allergic rhinitisQ36563846
Immunoregulatory function of mesenchymal stem cellsQ36609696
Immune regulation by mesenchymal stem cells: two sides to the coinQ36703067
Indoleamine 2,3-dioxygenase in immune suppression and cancer.Q36737697
Immunomodulatory properties of mesenchymal stromal cellsQ36896799
Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review).Q37091784
Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10.Q37241672
Relationship between T-lymphocyte cytokine levels and sero-response to hepatitis B vaccinesQ37277444
Mesenchymal stem cells suppress B-cell terminal differentiation.Q37355322
Human umbilical cord mesenchymal stem cells and the treatment of spinal cord injury.Q37383664
Mesenchymal stem cells: a new strategy for immunosuppression and tissue repairQ37724579
Immunosuppression by mesenchymal stem cells: mechanisms and clinical applicationsQ37760962
Immunological aspects of allogeneic mesenchymal stem cell therapiesQ37780764
Mesenchymal Stem Cells: Mechanisms of InflammationQ37809081
Immunomodulatory properties of mesenchymal stem cells: cytokines and factors.Q37939411
CD4⁺T cells: differentiation and functionsQ37999790
On the interactions between mesenchymal stem cells and regulatory T cells for immunomodulation in transplantationQ38013107
CD200/CD200R paired potent inhibitory molecules regulating immune and inflammatory responses; Part I: CD200/CD200R structure, activation, and function.Q38018612
Isolation and animal serum free expansion of human umbilical cord derived mesenchymal stromal cells (MSCs) and endothelial colony forming progenitor cells (ECFCs)Q38272382
Cord-blood-derived mesenchymal stromal cells downmodulate CD4+ T-cell activation by inducing IL-10-producing Th1 cellsQ39296574
Human placenta-derived mesenchymal stem cells suppress T cell proliferation and support the culture expansion of cord blood CD34⁺ cells: a comparison with human bone marrow-derived mesenchymal stem cellsQ39529152
Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity.Q39531156
Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype.Q39698715
Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-betaQ39716192
Brief report--human embryonic stem cell-derived mesenchymal progenitors possess strong immunosuppressive effects toward natural killer cells as well as T lymphocytesQ39920526
Mesenchymal Stem Cells - Sources and Clinical ApplicationsQ40138962
Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot studyQ40321403
Interactions between human mesenchymal stem cells and natural killer cellsQ40385365
Immune regulatory properties of multipotent mesenchymal stromal cells: Where do we stand?Q41807857
Multiplex analysis of cytokines, chemokines, growth factors, MMP-9 and TIMP-1 produced by human bone marrow, adipose tissue, and placental mesenchymal stromal cellsQ42503938
Umbilical cord-derived mesenchymal stromal cells modulate monocyte function to suppress T cell proliferation.Q42845624
Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells.Q42922142
Mesenchymal stromal cells use PGE2 to modulate activation and proliferation of lymphocyte subsets: Combined comparison of adipose tissue, Wharton's Jelly and bone marrow sourcesQ42974571
Ex vivo expansion of human mesenchymal stem cells: a more effective cell proliferation kinetics and metabolism under hypoxia.Q43216186
Galectin-1 and semaphorin-3A are two soluble factors conferring T-cell immunosuppression to bone marrow mesenchymal stem cellQ43249326
Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantationQ44317237
Evidence for the involvement of galectin-3 in mesenchymal stem cell suppression of allogeneic T-cell proliferationQ44599908
Allogenic mesenchymal stem cell transplantation ameliorates nephritis in lupus mice via inhibition of B-cell activationQ44985029
Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytesQ45024308
Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells.Q45834735
Fetal BM-derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cellsQ45844247
Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 inductionQ45880435
Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues.Q45927700
Mesenchymal stromal cells promote or suppress the proliferation of T lymphocytes from cord blood and peripheral blood: the importance of low cell ratio and role of interleukin-6.Q45946882
The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes.Q46010474
Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanismsQ46390299
The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector functionQ46576236
Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2.Q46939105
Mesenchymal stem cells from human bone marrow or adipose tissue differently modulate mitogen-stimulated B-cell immunoglobulin production in vitroQ47923725
Quantification and immunophenotypic characterization of bone marrow and umbilical cord blood mesenchymal stem cells by multicolor flow cytometry.Q50453265
Genetically modified adipose tissue-derived mesenchymal stem cells overexpressing CXCR4 display increased motility, invasiveness, and homing to bone marrow of NOD/SCID mice.Q50524510
Human mesenchymal stem cells from adipose tissue and amnion influence T-cells depending on stimulation method and presence of other immune cells.Q50543459
Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.Q50767537
Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide.Q52008649
Mesenchymal stromal cells inhibit Th17 but not regulatory T-cell differentiation.Q53281677
Mesenchymal stem cells stimulate antibody secretion in human B cells.Q53563416
Human mesenchymal stem cells derived from induced pluripotent stem cells down-regulate NK-cell cytolytic machinery.Q54462820
Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway.Q54671130
Mesenchymal stromal cells up-regulate CD39 and increase adenosine production to suppress activated T-lymphocytesQ56787014
Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interactionQ56901258
Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotypeQ56902900
P433issue5
P921main subjectumbilical cord mesenchymal stem cellQ107296590
P304page(s)125
P577publication date2013-10-15
P1433published inStem Cell Research & TherapyQ14390536
P1476titleMesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells
P478volume4

Reverse relations

cites work (P2860)
Q34601943Adipose-derived stromal cells promote allograft tolerance induction
Q36272379Basic Fibroblast Growth Factor Inhibits Apoptosis and Promotes Proliferation of Adipose-Derived Mesenchymal Stromal Cells Isolated from Patients with Type 2 Diabetes by Reducing Cellular Oxidative Stress
Q33872923Bone Marrow Mesenchymal Stem Cells Inhibit the Function of Dendritic Cells by Secreting Galectin-1.
Q50628184Bone Marrow Mesenchymal Stromal Cells Induce Proliferative, Cytokinic and Molecular Changes During the T Cell Response: The Importance of the IL-10/CD210 Axis.
Q90319531Bone marrow derived mesenchymal stem cells ameliorate inflammatory response in an in vitro model of familial hemophagocytic lymphohistiocytosis 2
Q52994215Bone marrow mesenchymal stem cells suppressing activation of allogeneic cytokine-induced killer/natural killer cells either by direct or indirect interaction.
Q34803754Changes in immunological profile of allogeneic mesenchymal stem cells after differentiation: should we be concerned?
Q50190841Characterization of Sox9-overexpressing human umbilical cord blood-derived mesenchymal stem cells-based engineered cartilage both in vitro and in vivo
Q57169681Chronic Niche Inflammation in Endometriosis-Associated Infertility: Current Understanding and Future Therapeutic Strategies
Q64109237Comparative study of the neural differentiation capacity of mesenchymal stromal cells from different tissue sources: An approach for their use in neural regeneration therapies
Q26822005Comparing the Immunomodulatory Properties of Bone Marrow, Adipose Tissue, and Birth-Associated Tissue Mesenchymal Stromal Cells
Q64084614Comparison of Mesenchymal Stromal Cells From Different Origins for the Treatment of Graft-vs.-Host-Disease in a Humanized Mouse Model
Q65000505Comparison of therapeutic effects of different mesenchymal stem cells on rheumatoid arthritis in mice.
Q58702140Current Strategies to Generate Human Mesenchymal Stem Cells In Vitro
Q64113492Delivery of oncolytic vaccinia virus by matched allogeneic stem cells overcomes critical innate and adaptive immune barriers
Q34428273Differentiation of human umbilical cord matrix mesenchymal stem cells into neural-like progenitor cells and maturation into an oligodendroglial-like lineage
Q49177046Does the Mesenchymal Stem Cell Source Influence Smooth Muscle Regeneration in Tissue-Engineered Urinary Bladders?
Q64966372Effect of Comedications and Endotoxins on Mesenchymal Stem Cell Secretomes, Migratory and Immunomodulatory Capacity.
Q35562203Effect of human bone marrow mesenchymal stromal cells on cytokine production by peripheral blood naive, memory, and effector T cells
Q50248506Effects of local administration of allogenic adipose tissue-derived mesenchymal stem cells on functional recovery in experimental traumatic brain injury
Q54989352Genetic contribution to mesenchymal stem cell dysfunction in systemic lupus erythematosus.
Q28071840Genetically modified mesenchymal stromal cells in cancer therapy
Q39803218Growth suppression effect of human mesenchymal stem cells from bone marrow, adipose tissue, and Wharton's jelly of umbilical cord on PBMCs
Q43576209Haploidentical hematopoietic stem cell transplant with umbilical cord-derived multipotent mesenchymal cell infusion for the treatment of high-risk acute leukemia in children
Q40548665Human Bone Marrow-Derived Mesenchymal Stromal Cells Differentially Inhibit Cytokine Production by Peripheral Blood Monocytes Subpopulations and Myeloid Dendritic Cells.
Q36805987Human Liver Stem Cells Suppress T-Cell Proliferation, NK Activity, and Dendritic Cell Differentiation
Q35580306Human Umbilical Cord Mesenchymal Stem Cells Inhibit the Function of Allogeneic Activated Vγ9Vδ2 T Lymphocytes In Vitro
Q33805077Human adipose-derived mesenchymal stem cells alleviate obliterative bronchiolitis in a murine model via IDO.
Q49587686Immunological impact of Wharton's Jelly mesenchymal stromal cells and natural killer cell co-culture
Q94503661Immunomodulatory Effect of Adipose-Derived Stem Cells: The Cutting Edge of Clinical Application
Q38775114Immunomodulatory effects of bone marrow versus adipose tissue-derived mesenchymal stromal cells on NK cells: implications in the transplantation setting
Q27026892Immunoregulation by mesenchymal stem cells: biological aspects and clinical applications
Q26770107Immunotolerant Properties of Mesenchymal Stem Cells: Updated Review
Q35078827In vitro augmentation of mesenchymal stem cells viability in stressful microenvironments : In vitro augmentation of mesenchymal stem cells viability
Q58776448Infrapatellar Fat Pad-Derived Stem Cell-Based Regenerative Strategies in Orthopedic Surgery
Q42291750In Vitro Generation of Vascular Wall-Resident Multipotent Stem Cells of Mesenchymal Nature from Murine Induced Pluripotent Stem Cells
Q42362354Membrane particles generated from mesenchymal stromal cells modulate immune responses by selective targeting of pro-inflammatory monocytes
Q33569871Mesenchymal Stem Cell Therapy Protects Lungs from Radiation-Induced Endothelial Cell Loss by Restoring Superoxide Dismutase 1 Expression
Q88884604Mesenchymal Stem Cell-Based Therapy for Cardiovascular Disease: Progress and Challenges
Q64108180Mesenchymal Stem Cells Improve Rheumatoid Arthritis Progression by Controlling Memory T Cell Response
Q28354224Mesenchymal Stem Cells as Therapeutic Candidates for Halting the Progression of Diabetic Nephropathy
Q90459409Mesenchymal Stem Cells for the Treatment of Liver Disease: Present and Perspectives
Q57300327Mesenchymal Stem Cells in Primary Sjögren's Syndrome: Prospective and Challenges
Q26746104Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?
Q46374324Mesenchymal stem cell therapy: A promising cell-based therapy for treatment of myocardial infarction
Q26770191Mesenchymal stem cells and immunomodulation: current status and future prospects
Q28828416Mesenchymal stem cells in corneal neovascularization: Comparison of different application routes
Q59790772Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review
Q38733373Mesenchymal stromal cell therapy for the treatment of intestinal ischemia: Defining the optimal cell isolate for maximum therapeutic benefit
Q37661559Mesenchymal stromal cells as vehicles of tetravalent bispecific Tandab (CD3/CD19) for the treatment of B cell lymphoma combined with IDO pathway inhibitor D-1-methyl-tryptophan
Q49924219Mesenchymal stromal cells of the bone marrow and natural killer cells: cell interactions and cross modulation.
Q48234353Molecular and Cellular Mechanisms Involved in Mesenchymal Stem Cell-Based Therapy of Inflammatory Bowel Diseases.
Q89557788Multidose intramuscular allogeneic adipose stem cells decrease the severity of canine atopic dermatitis: A pilot study
Q34786543Potential therapeutic effect of the secretome from human uterine cervical stem cells against both cancer and stromal cells compared with adipose tissue stem cells
Q64249676Production of Mesenchymal Stem Cells Through Stem Cell Reprogramming
Q36440734Propranolol and Mesenchymal Stromal Cells Combine to Treat Traumatic Brain Injury
Q90558489Regenerative therapy by endometrial mesenchymal stem cells in thin endometrium with repeated implantation failure. A novel strategy
Q39017821Review article: mesenchymal stromal cell therapy for inflammatory bowel diseases
Q91783625Similarities and differences between mesenchymal stem/progenitor cells derived from various human tissues
Q38648343Stem cells - biological update and cell therapy progress
Q91637582The Achievements and Challenges of Mesenchymal Stem Cell-Based Therapy in Inflammatory Bowel Disease and Its Associated Colorectal Cancer
Q103829366The Chemokine Receptors Ccr5 and Cxcr6 Enhance Migration of Mesenchymal Stem Cells into the Degenerating Retina
Q47229258The Clinical Applications of Endometrial Mesenchymal Stem Cells
Q45913373The Immunomodulatory Effects of Mesenchymal Stem Cell Polarization within the Tumor Microenvironment Niche.
Q26779265The Long Path of Human Placenta, and Its Derivatives, in Regenerative Medicine
Q90151295The Safe and Efficacious Use of Secretome From Fibroblasts and Adipose-derived (but not Bone Marrow-derived) Mesenchymal Stem Cells for Skin Therapeutics
Q26781292The immune response of stem cells in subretinal transplantation
Q41869342The injury progression of T lymphocytes in a mouse model with subcutaneous injection of a high dose of sulfur mustard.
Q35206489The multiple functional roles of mesenchymal stem cells in participating in treating liver diseases
Q33563134The regulation of inflammatory mediators in acute kidney injury via exogenous mesenchymal stem cells.
Q92394670Therapeutic Potential of Mesenchymal Stem Cells in Immune-Mediated Diseases
Q52593734Therapeutic Use of Stem Cells for Myocardial Infarction.
Q28076187Therapeutic use of stem cells for cardiovascular disease
Q88601047Transplantation of adipose tissue-derived stem cells ameliorates autoimmune pathogenesis in MRL/lpr mice : Modulation of the balance between Th17 and Treg
Q35844400Transplanted Umbilical Cord Mesenchymal Stem Cells Modify the In Vivo Microenvironment Enhancing Angiogenesis and Leading to Bone Regeneration
Q35866047iPSC-MSCs Combined with Low-Dose Rapamycin Induced Islet Allograft Tolerance Through Suppressing Th1 and Enhancing Regulatory T-Cell Differentiation

Search more.